P4 medicine and Osteoporosis: A systematic Review

Overview

Journal Wien Klin Wochenschr

Publisher Springer

Specialty General Medicine

Date 2016 Nov 23

PMID 27873024

Citations 5

Authors

Klemen Kodric

Klemen camernik

Darko cerne

Radko Komadina

Janja Marc

Affiliations

Soon will be listed here.

Abstract

Background: Osteoporosis is the most frequent bone metabolic disease. In order to improve early detection, prediction, prevention, diagnosis, and treatment of the disease, a new model of P4 medicine (personalized, predictive, preventive, and participatory medicine) could be applied. The aim of this work was to systematically review the publications of four different types of "omics" studies related to osteoporosis, in order to discover novel predictive, preventive, diagnostic, and therapeutic targets for better management of the geriatric population.

Methods: To systematically search the PubMed database, we created specific groups of criteria for four different types of "omics" information on osteoporosis: genomic, transcriptomic, proteomic, and metabolomic. We then analyzed the intersections between them in order to find correlations and common pathways or molecules with important roles in osteoporosis, and with a potential application in disease prediction, prevention, diagnosis, or treatment.

Results: Altogether, 180 publications of "omics" studies in the field of osteoporosis were found and reviewed at first selection. After introducing the inclusion and exclusion criteria (the secondary selection), 46 papers were included in the systematic review.

Conclusions: The intersection of reviewed papers identified five genes (ESR1, IBSP, CTNNB1, SOX4, and IDUA) and processes like the Wnt pathway, JAK/STAT signaling, and ERK/MAPK, which should be further validated for their predictive, diagnostic, or other clinical value in osteoporosis. Such molecular insights will enable us to fit osteoporosis into the P4 strategy and could increase the effectiveness of disease prediction and prevention, with a decrease in morbidity in the geriatric population.

Citing Articles

SOXC Transcription Factors as Diagnostic Biomarkers and Therapeutic Targets for Arthritis.

Ahmed E, Alzahrani A Int J Mol Sci. 2023; 24(4).

PMID: 36835620 PMC: 9967432. DOI: 10.3390/ijms24044215.

Application of metabolomics in osteoporosis research.

Zhao Z, Cai Z, Chen A, Cai M, Yang K Front Endocrinol (Lausanne). 2022; 13:993253.

PMID: 36452325 PMC: 9702081. DOI: 10.3389/fendo.2022.993253.

MiR-214 regulates fracture healing through inhibiting Sox4 and its mechanism.

Xin Z, Cai D, Wang J, Ma L, Shen F, Tang C J Musculoskelet Neuronal Interact. 2020; 20(3):429-436.

PMID: 32877980 PMC: 7493443.

Predictive, Personalized, Preventive and Participatory (4P) Medicine Applied to Telemedicine and eHealth in the Literature.

Gongora Alonso S, Diez I, Garcia Zapirain B J Med Syst. 2019; 43(5):140.

PMID: 30976942 DOI: 10.1007/s10916-019-1279-4.

Towards a systems approach for chronic diseases, based on health state modeling.

Rebhan M F1000Res. 2017; 6:309.

PMID: 28529704 PMC: 5419256. DOI: 10.12688/f1000research.11085.1.

References

Wu X, Guo S, Shen G, Ma X, Tang C, Xie K . Screening of osteoprotegerin-related feature genes in osteoporosis and functional analysis with DNA microarray. Eur J Med Res. 2013; 18:15. PMC: 3735399. DOI: 10.1186/2047-783X-18-15. View

Liu X, Liu Y, Cheng M, Zhang X, Xiao H . A metabolomics study of the inhibitory effect of 17-beta-estradiol on osteoclast proliferation and differentiation. Mol Biosyst. 2014; 11(2):635-46. DOI: 10.1039/c4mb00528g. View

You Y, Lin C, Liang H, Lee S, Tsai K, Chiou J . Association between the metabolome and low bone mineral density in Taiwanese women determined by (1)H NMR spectroscopy. J Bone Miner Res. 2013; 29(1):212-22. DOI: 10.1002/jbmr.2018. View

Golchin M, Heidari L, Ghaderian S, Akhavan-Niaki H . Osteoporosis: A Silent Disease with Complex Genetic Contribution. J Genet Genomics. 2016; 43(2):49-61. DOI: 10.1016/j.jgg.2015.12.001. View

Paternoster L, Lorentzon M, Vandenput L, Karlsson M, Ljunggren O, Kindmark A . Genome-wide association meta-analysis of cortical bone mineral density unravels allelic heterogeneity at the RANKL locus and potential pleiotropic effects on bone. PLoS Genet. 2010; 6(11):e1001217. PMC: 2987837. DOI: 10.1371/journal.pgen.1001217. View

Hood L, Balling R, Auffray C . Revolutionizing medicine in the 21st century through systems approaches. Biotechnol J. 2012; 7(8):992-1001. PMC: 3962497. DOI: 10.1002/biot.201100306. View

Styrkarsdottir U, Halldorsson B, Gretarsdottir S, Gudbjartsson D, Walters G, Ingvarsson T . Multiple genetic loci for bone mineral density and fractures. N Engl J Med. 2008; 358(22):2355-65. DOI: 10.1056/NEJMoa0801197. View

Zhang L, Choi H, Estrada K, Leo P, Li J, Pei Y . Multistage genome-wide association meta-analyses identified two new loci for bone mineral density. Hum Mol Genet. 2013; 23(7):1923-33. PMC: 3943521. DOI: 10.1093/hmg/ddt575. View

Guo Y, Tan L, Lei S, Yang T, Chen X, Zhang F . Genome-wide association study identifies ALDH7A1 as a novel susceptibility gene for osteoporosis. PLoS Genet. 2010; 6(1):e1000806. PMC: 2794362. DOI: 10.1371/journal.pgen.1000806. View

10.

Duncan E, Danoy P, Kemp J, Leo P, McCloskey E, Nicholson G . Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk. PLoS Genet. 2011; 7(4):e1001372. PMC: 3080863. DOI: 10.1371/journal.pgen.1001372. View

11.

Xiao S, Kung A, Gao Y, Lau K, Ma A, Zhang Z . Post-genome wide association studies and functional analyses identify association of MPP7 gene variants with site-specific bone mineral density. Hum Mol Genet. 2011; 21(7):1648-57. DOI: 10.1093/hmg/ddr586. View

12.

Pineda B, Serna E, Laguna-Fernandez A, Noguera I, Panach L, Hermenegildo C . Gene expression profile induced by ovariectomy in bone marrow of mice: a functional approach to identify new candidate genes associated to osteoporosis risk in women. Bone. 2014; 65:33-41. DOI: 10.1016/j.bone.2014.05.001. View

13.

Estrada K, Styrkarsdottir U, Evangelou E, Hsu Y, Duncan E, Ntzani E . Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet. 2012; 44(5):491-501. PMC: 3338864. DOI: 10.1038/ng.2249. View

14.

Rivadeneira F, Styrkarsdottir U, Estrada K, Halldorsson B, Hsu Y, Richards J . Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet. 2009; 41(11):1199-206. PMC: 2783489. DOI: 10.1038/ng.446. View

15.

Guo Y, Wang J, Liu H, Li M, Yang T, Zhang X . Are bone mineral density loci associated with hip osteoporotic fractures? A validation study on previously reported genome-wide association loci in a Chinese population. Genet Mol Res. 2012; 11(1):202-10. PMC: 3682464. DOI: 10.4238/2012.January.31.1. View

16.

Xie W, Ji L, Zhao T, Gao P . Identification of transcriptional factors and key genes in primary osteoporosis by DNA microarray. Med Sci Monit. 2015; 21:1333-44. PMC: 4436946. DOI: 10.12659/MSM.894111. View

17.

Kanis J, Johnell O, Oden A, Johansson H, De Laet C, Eisman J . Smoking and fracture risk: a meta-analysis. Osteoporos Int. 2004; 16(2):155-62. DOI: 10.1007/s00198-004-1640-3. View

18.

Qi H, Bao J, An G, Ouyang G, Zhang P, Wang C . Association between the metabolome and bone mineral density in pre- and post-menopausal Chinese women using GC-MS. Mol Biosyst. 2016; 12(7):2265-75. DOI: 10.1039/c6mb00181e. View

19.

Xiao P, Chen Y, Jiang H, Liu Y, Pan F, Yang T . In vivo genome-wide expression study on human circulating B cells suggests a novel ESR1 and MAPK3 network for postmenopausal osteoporosis. J Bone Miner Res. 2008; 23(5):644-54. PMC: 2674539. DOI: 10.1359/jbmr.080105. View

20.

Hui S, Slemenda C, JOHNSTON Jr C . Age and bone mass as predictors of fracture in a prospective study. J Clin Invest. 1988; 81(6):1804-9. PMC: 442628. DOI: 10.1172/JCI113523. View